Jpmorgan Chase & CO ALNYLAM PHARMACEUTICALS INC Call Options Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2025

May 12, 2025
BUY
N/A
8,800 New
8,800 $0
Q2 2024

Dec 26, 2024
BUY
N/A
22,000 New
22,000 $0
Q2 2024

Aug 12, 2024
BUY
N/A
2,000 Added 10.0%
22,000 $0
Q1 2024

Dec 26, 2024
BUY
N/A
20,000 New
20,000 $0
Q4 2023

Dec 26, 2024
BUY
N/A
20,000 New
20,000 $0
Q4 2023

Feb 12, 2024
BUY
N/A
20,000 New
20,000 $0
Q1 2023

May 11, 2023
BUY
N/A
7,500 New
7,500 $0
Q3 2022

Nov 14, 2022
SELL
N/A
-71,300 Reduced 84.78%
12,800 $2.56 Million
Q2 2022

Aug 11, 2022
BUY
N/A
12,800 Added 17.95%
84,100 $12.3 Million
Q1 2022

May 11, 2022
SELL
N/A
-121,200 Reduced 62.96%
71,300 $11.6 Million
Q4 2021

Feb 10, 2022
BUY
N/A
192,500 New
192,500 $32.6 Million
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email